/
NHS
$6.21+$0.03 (+0.40%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$193.2M
32M shares
52-week range
$6.06 – $7.75
9% from low
Exchange
XASE
FUND
Borrow rate
4.07%
Moderate
Price (6 mo)
Loading chart…
Change$-7.21
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | −$834.7K | $25.5M | $9.2M | $29.5M | $9.5M | $22.4M | $41.7M | $26.7M |
| Cost of revenue | $2.7M | $2.9M | $2.9M | $0 | $2.0M | $3.1M | $0 | $2.2M |
| Gross profit | −$3.5M | $22.6M | $6.3M | $29.5M | $7.5M | $22.4M | $41.7M | $24.5M |
| Gross margin | 424.8% | 88.5% | 68.7% | 100.0% | 79.2% | 100.0% | 100.0% | 91.6% |
| R&D | −$0 | $0 | $0 | $0 | −$4 | $0 | $0 | $0 |
| Operating income | −$137.7K | $22.5M | $6.7M | $29.1M | −$29.9M | $12.1M | $37.9M | $25.4M |
| EBITDA | $19.4M | $22.5M | $6.7M | $29.1M | −$29.9M | $12.1M | $37.9M | $25.4M |
| Net income | −$3.1M | $22.5M | $3.0M | $26.8M | −$33.5M | $3.7M | $37.9M | $20.2M |
| Net margin | 370.5% | 88.3% | 33.0% | 90.8% | -351.4% | 16.6% | 90.9% | 75.7% |
| EPS (diluted) | -0.16 | 1.15 | 0.08 | 0.69 | -0.86 | 0.14 | 1.44 | 0.66 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$17.33
Price
$6.21
Implied upside
+179%
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| NHSNeuberger High Yield Strategies Fund Inc. | $6.19 | +0.19% | $194M | — |
| BIPIXProFunds Biotechnology UltraSector Fund Investor Class | $96.41 | +2.69% | $376M | — |
| DOPIXBNY Mellon Opportunistic Small Cap Fund Class I | $36.09 | +1.09% | $236M | — |
| EMEAXAshmore Emerging Markets Equity Fund | $19.12 | +1.00% | $338M | — |
| EMFIXAshmore Emerging Markets Equity Fund - Institutional Class |
Neuberger High Yield Strategies Fund Inc.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
www.nb.com- IPO / List date
- Jul 29, 2003
Held by traders on TradeandTell
No one on the platform currently holds NHS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NHS as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 5.83% ($0.36/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-15 | $0.0905 | 2026-06-30 |
| 2026-05-15 | $0.0905 | 2026-05-29 |
| 2026-04-07 | $0.0905 | 2026-04-30 |
| 2026-03-16 | $0.0905 | 2026-03-31 |
| 2026-02-17 | $0.0905 | 2026-02-27 |
| 2026-01-15 | $0.0905 | 2026-01-30 |
| 2025-12-15 | $0.0905 | 2025-12-31 |
| 2025-11-17 | $0.0905 | 2025-11-28 |
| 2025-10-15 | $0.0905 | 2025-10-31 |
| 2025-09-15 | $0.0905 | 2025-09-30 |
Recent trades on TradeandTell
No one on the platform has traded NHS yet.
